» Articles » PMID: 39108856

Recurrent Lacrimal Gland Adenoid Cystic Carcinoma: A Case Report and Literature Review

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Aug 7
PMID 39108856
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Lacrimal gland adenoid cystic carcinoma (LGACC) is characterized by a high rate of recurrence, perineural invasion, and propensity for distant metastasis, resulting in poor prognosis. This case report aimed to highlight the diagnostic and therapeutic challenges of LGACC, underscore the importance of resectioning the tumor as completely as possible for the first time, adhere to postoperative adjuvant therapy, and provide detailed insights into its surgical and diagnostic management that may not be extensively covered in large case series and meta-analyses.

Case Presentation: A 34-year-old man presented with progressive left eye proptosis for 4 months. Initial evaluation and imaging led to a high suspicion of LGACC, which was confirmed after an eye-sparing excision of the left orbital tumor. The patient declined to undergo postoperative radiotherapy, which was recommended after the surgery. Thus, despite surgical intervention, the patient experienced tumor recurrence 3 months post-surgery, leading to orbital exenteration. Pathological examination confirmed the presence of poorly differentiated LGACC.This time the patient underwent postoperative radiotherapy, as recommended. However, despite local control, the patient developed an intracranial metastasis within a year.

Conclusion: LGACC presents significant diagnostic and therapeutic challenges owing to its insidious onset, lack of specific symptoms, and high potential for recurrence and metastasis. Thus, this case emphasizes the need for early diagnosis, aggressive treatment, and adherence to postoperative adjuvant therapy to improve patient outcomes. Future research should focus on understanding the pathogenesis of LGACC and on developing standardized diagnostic and treatment protocols to enhance patient prognosis and survival.

References
1.
Gondivkar S, Gadbail A, Chole R, Parikh R . Adenoid cystic carcinoma: a rare clinical entity and literature review. Oral Oncol. 2011; 47(4):231-6. DOI: 10.1016/j.oraloncology.2011.01.009. View

2.
Goldberg H, Jiang X, Fan J, Zhao J, Ning J, Williams M . Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma. Ophthalmic Plast Reconstr Surg. 2024; 40(4):419-425. PMC: 11226383. DOI: 10.1097/IOP.0000000000002606. View

3.
Yan H, Liu R, Wang N, Xu L, Guo Q, Li J . Treatment of lacrimal gland adenoid cystic carcinoma: a systematic review and Meta-analysis. Int J Ophthalmol. 2024; 17(1):164-172. PMC: 10754659. DOI: 10.18240/ijo.2024.01.22. View

4.
Townsend D, Carney J, Yap J, Hall N . PET/CT today and tomorrow. J Nucl Med. 2004; 45 Suppl 1:4S-14S. View

5.
Andreasen S, Esmaeli B, von Holstein S, Mikkelsen L, Rasmussen P, Heegaard S . An Update on Tumors of the Lacrimal Gland. Asia Pac J Ophthalmol (Phila). 2017; 6(2):159-172. DOI: 10.22608/APO.201707. View